Related Experiment Videos
Developmental toxicology in the 21st century: multidisciplinary approaches using model organisms and genomics
Philip Mirkes1, Michael E McClure, Jerrold J Heindel
1Department of Pediatrics, University of Washington, Seattle, Washington, USA.
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Reducing exposure to non-persistent endocrine-disrupting chemicals and their impact on human health: Evidence from dietary, behavioral, and residential interventions.
Ecotoxicology and environmental safety·2026
Controlled Introduction of sp3 Quantum Defects in Fluorescent Carbon Nanotubes by Mechanochemistry.
Angewandte Chemie (International ed. in English)·2025
Consensus on the key characteristics of metabolism disruptors.
Nature reviews. Endocrinology·2024
A toxic relationship: ultra-processed foods & plastics.
Globalization and health·2024
Association between antibiotic use among pregnant women with urinary tract infections in the first trimester and birth defects, National Birth Defects Prevention Study 1997 to 2011.
Birth defects research. Part A, Clinical and molecular teratology·2016
Evaluation of the Western Australian Register of Developmental Anomalies: Thirty-five years of surveillance.
Birth defects research. Part A, Clinical and molecular teratology·2016
A quality assessment of reporting sources for microcephaly in Utah, 2003 to 2013.
Birth defects research. Part A, Clinical and molecular teratology·2016
Editorial brain malformation surveillance in the Zika era.
Birth defects research. Part A, Clinical and molecular teratology·2016
Characterizing facial features in individuals with craniofacial microsomia: A systematic approach for clinical research.
Birth defects research. Part A, Clinical and molecular teratology·2016
Population-based microcephaly surveillance in the United States, 2009 to 2013: An analysis of potential sources of variation.
Birth defects research. Part A, Clinical and molecular teratology·2016
Targeting glycine transporter type 1 (GlyT1) in epilepsy: Pathophysiological rationale and therapeutic perspectives.
Pharmacology & therapeutics·2026
[Autism - Phenotypic variability].
Medicina·2026
Two Novel Compound Heterozygous CDH23 Mutations Underlying Non-Syndromic Hearing Loss.
International journal of general medicine·2026